MedTrace Logo

Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia

NCT01763658 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2013-01-09

No results posted yet for this study

Summary

Oxidative stress occurs as a result of increased activity of free radical-producing enzymes, decreased activity of free radical-removing enzymes, and insufficient levels of antioxidants. The most sensitive molecules to oxidation are lipids. Loss of cell membrane elasticity, increased cell fragility, and a shortened cellular life span results from oxidation of cell membrane lipids.

Conditions

Interventions

DRUG

Antox tablets(Mepaco)

effect of antioxidant on disease outcome

OTHER

drug therapy for ITP

drugs will be selected according to ASH,2011 guidelines

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Mohsen S Elalfy, professor · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01763658 on ClinicalTrials.gov